Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,062.28
(
-1.26%
)
News Focus
News Focus
Post# of 257579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 73654

Thursday, 02/26/2009 7:58:56 AM

Thursday, February 26, 2009 7:58:56 AM

Post# of 257579
Re: R7128 phase-2 trial design

Isn’t it odd that the actual design differs in so many respects from the intended design described in the 1/12/09 PR? I’m not sure whether having three trials arms with the 90mcg “half” Pegasys dose (including one arm that tests 90mcg Pegasys with the extra-high 1500mg BID dose of R7128) should be viewed as bullish or bearish for R7128.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today